General Information of the Cell Line
Cell Line ID
CL000001
Cell Line Name
Jurkat
Synonyms
JURKAT
JM
JM-Jurkat
Jurkat-FHCRC
Jurkat FHCRC
FHCRC-11
FHCRC subclone 11
FCCH1024
Category
Cancer cell line
Organism
Homo sapiens (Human)
Cellosaurus ID
CVCL_0065
Tissue Information
Peripheral blood
Disease
Childhood T acute lymphoblastic leukemia (NCIt: C7953)
Precursor T-cell acute lymphoblastic leukemia (ORDO: Orphanet_99861)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT01278, Adenosine receptor A2b
Compound ID Compound Name Compound Formula
CP0377686
8-(4-(4-(4-Chlorophenyl)piperazine-1-sulfonyl)phenyl)-1-propyl-3,7-dihydropurine-2,6-dione
   Show/Hide
C24H25ClN6O4S
 1
1
IC50 = 1.13 nM
   TI
   LI
   LO
   TS
CP0495409
1-Propyl-8-(4-(4-(4-trifluoromethylbenzyl)piperazine-1-sulfonyl)phenyl)-3,7-dihydropurine-2,6-dione
   Show/Hide
C26H27F3N6O4S
 1
1
IC50 = 1.62 nM
   TI
   LI
   LO
   TS
CP0498543
8-(4-(4-(3-Chlorobenzyl)piperazine-1-sulfonyl)phenyl)-1-propyl-3,7-dihydropurine-2,6-dione
   Show/Hide
C25H27ClN6O4S
 1
1
IC50 = 1.91 nM
   TI
   LI
   LO
   TS
CP0431394
1-Ethyl-8-(4-(4-(3-trifluoromethylbenzyl)piperazine-1-sulfonyl)phenyl)-3,7-dihydropurine-2,6-dione
   Show/Hide
C25H25F3N6O4S
 1
1
IC50 = 2.29 nM
   TI
   LI
   LO
   TS
CP0377682
8-(4-(4-(3-Fluorobenzyl)piperazine-1-sulfonyl)phenyl)-1-propyl-3,7-dihydropurine-2,6-dione
   Show/Hide
C25H27FN6O4S
 1
1
IC50 = 3.23 nM
   TI
   LI
   LO
   TS
CP0388100
1-Propyl-8-(4-(4-(3-trifluoromethylbenzyl)piperazine-1-sulfonyl)phenyl)-3,7-dihydropurine-2,6-dione
   Show/Hide
C26H27F3N6O4S
 1
1
IC50 = 3.56 nM
   TI
   LI
   LO
   TS
CP0387534
8-(4-(4-(4-chlorobenzyl)piperazin-1-ylsulfonyl)phenyl)-1-propyl-1H-purine-2,6(3H,7H)-dione
   Show/Hide
C25H27ClN6O4S
 1
1
IC50 = 3.64 nM
   TI
   LI
   LO
   TS
CP0439717
8-(4-(4-benzylpiperazin-1-ylsulfonyl)phenyl)-1-ethyl-1H-purine-2,6(3H,7H)-dione
   Show/Hide
C24H26N6O4S
 1
1
IC50 = 4.49 nM
   TI
   LI
   LO
   TS
CP0427209
1-Ethyl-8-(4-(4-(4-methoxybenzyl)piperazine-1-sulfonyl)phenyl)-3,7-dihydropurine-2,6-dione
   Show/Hide
C25H28N6O5S
 1
1
IC50 = 5.26 nM
   TI
   LI
   LO
   TS
CP0388501
8-(4-(4-Benzo[1,3]dioxol-5-ylmethylpiperazine-1-sulfonyl)phenyl)-1-ethyl-3,7-dihydropurine-2,6-dione
   Show/Hide
C25H26N6O6S
 1
1
IC50 = 5.34 nM
   TI
   LI
   LO
   TS
CP0234416
8-(4-(4-benzylpiperazin-1-ylsulfonyl)phenyl)-1-propyl-1H-purine-2,6(3H,7H)-dione
   Show/Hide
C25H28N6O4S
 1
1
IC50 = 10.1 nM
   TI
   LI
   LO
   TS
CP0377685
8-(4-(4-Phenethylpiperazine-1-sulfonyl)phenyl)-1-propyl-3,7-dihydropurine-2,6-dione
   Show/Hide
C26H30N6O4S
 1
1
IC50 = 10.9 nM
   TI
   LI
   LO
   TS
CP0388500
8-(4-(4-(4-Methoxybenzyl)piperazine-1-sulfonyl)phenyl)-1-propyl-3,7-dihydropurine-2,6-dione
   Show/Hide
C26H30N6O5S
 1
1
IC50 = 16.2 nM
   TI
   LI
   LO
   TS
CP0377681
8-(4-(4-Benzo[1,3]dioxol-5-ylmethylpiperazine-1-sulfonyl)phenyl)-1-propyl-3,7-dihydropurine-2,6-dione
   Show/Hide
C26H28N6O6S
 1
1
IC50 = 23.4 nM
   TI
   LI
   LO
   TS
Cell Viability or Cytotoxicity Assay
Compound ID Compound Name Compound Formula
CP0003832
N'-hydroxy-N-phenyloctanediamide
   Show/Hide
C14H20N2O3  2
1
IC50 = 590 nM
   TI
   LI
   LO
   TS
2
IC50 = 1490 nM
   TI
   LI
   LO
   TS
CP0004106
(2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8(13),9,11,14(28),15(19),20(27),21(26),22,24-nonaen-16-one
   Show/Hide
C28H26N4O3  1
1
IC50 = 71 nM
   TI
   LI
   LO
   TS
CP0010318
1-[3-[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-3,4-dihydroxyoxolan-2-yl]methyl-propan-2-ylamino]propyl]-3-(4-tert-butylphenyl)urea
   Show/Hide
C28H41N7O4  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0034844
HDAC inhibitor, Compound 1
   Show/Hide
C19H17N3O2S  1
1
CC50 = 12600 nM
   TI
   LI
   LO
   TS
CP0037987
N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine
   Show/Hide
C22H23N3O4  1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0043135
N-[1-(3-amino-3-oxopropyl)-5-[benzoyl(ethyl)amino]benzimidazol-2-yl]-4-cyanobenzamide
   Show/Hide
C27H24N6O3  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0048963
(3S,5R)-5-bromo-16-hydroxy-14-methoxy-3-methyl-3,4,5,6,9,10,11,12-octahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione
   Show/Hide
C19H25BrO5  1
1
IC50 = 11400 nM
   TI
   LI
   LO
   TS
CP0051649
6,6-dimethyl-N-[1-[(1R)-2-methylsulfonyl-1-phenylethyl]pyrazol-4-yl]-1,4,5,7-tetrahydroindazole-3-carboxamide
   Show/Hide
C22H27N5O3S  1
1
IC50 = 42000 nM
   TI
   LI
   LO
   TS
CP0051651
N-[1-[(1S)-3-(dimethylamino)-1-phenylpropyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide
   Show/Hide
C24H32N6O  1
1
IC50 = 4700 nM
   TI
   LI
   LO
   TS
CP0054958
(3S,5R,Z)-5-chloro-16-hydroxy-14-methoxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione
   Show/Hide
C19H23ClO5  1
1
IC50 = 9500 nM
   TI
   LI
   LO
   TS
CP0064592
[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate
   Show/Hide
C47H51NO14  1
1
GI50 < 10 nM
   TI
   LI
   LO
   TS
CP0073563
12,13-(2,3-Cis-dihyroxy-1,4-butyl)-6,7,12,13-tetrahydro-5-oxo-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole
   Show/Hide
C24H19N3O3  2
1
IC50 = 98 nM
   TI
   LI
   LO
   TS
2
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0093047
N-[1-(3-amino-3-oxopropyl)-5-[benzoyl(methyl)amino]benzimidazol-2-yl]-4-cyanobenzamide
   Show/Hide
C26H22N6O3  1
1
TC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0112599
US8569511, 2
   Show/Hide
C23H22F2N6O2  1
1
IC50 = 385 nM
   TI
   LI
   LO
   TS
CP0139001
N-(4-fluorophenyl)-1-methyl-3-[[methyl-[2-(4-phenylphenyl)ethyl]amino]methyl]indole-5-carboxamide
   Show/Hide
C32H30FN3O  1
1
IC50 = 2700 nM
   TI
   LI
   LO
   TS
CP0150245
2-ethylsulfanyl-3-methylnaphthalene-1,4-dione
   Show/Hide
C13H12O2S  1
1
IC50 = 3900 nM
   TI
   LI
   LO
   TS
CP0158685
CHEBI:64215
   Show/Hide
C12H10O4  1
1
IC50 = 11500 nM
   TI
   LI
   LO
   TS
CP0164465
2,3-bis(methylsulfanyl)naphthalene-1,4-dione
   Show/Hide
C12H10O2S2  1
1
IC50 = 1400 nM
   TI
   LI
   LO
   TS
CP0166540
N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]acetamide
   Show/Hide
C26H29N3O3  1
1
GI50 = 10 nM
   TI
   LI
   LO
   TS
CP0180683
(3S,5R,E)-5-bromo-16-hydroxy-14-methoxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione
   Show/Hide
C19H23BrO5  1
1
IC50 = 11700 nM
   TI
   LI
   LO
   TS
CP0201638
2-(1,4-dioxonaphthalen-2-yl)sulfanylpropanoic acid
   Show/Hide
C13H10O4S  1
1
IC50 = 17900 nM
   TI
   LI
   LO
   TS
CP0201640
2-(2-methoxyethylsulfanyl)-3-methylnaphthalene-1,4-dione
   Show/Hide
C14H14O3S  1
1
IC50 = 3200 nM
   TI
   LI
   LO
   TS
CP0233573
(3S,5R,Z)-5-bromo-16-hydroxy-14-methoxy-3-methyl-3,4,5,6,9,10-hexahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione
   Show/Hide
C19H23BrO5  2
1
IC50 = 6100 nM
   TI
   LI
   LO
   TS
2
IC50 = 7500 nM
   TI
   LI
   LO
   TS
CP0241066
(3S,5R)-5-chloro-16-hydroxy-14-methoxy-3-methyl-3,4,5,6,9,10,11,12-octahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione
   Show/Hide
C19H25ClO5  1
1
IC50 = 8400 nM
   TI
   LI
   LO
   TS
CP0271711
6,6-dimethyl-N-[1-[(1S)-3-methylsulfonyl-1-phenylpropyl]pyrazol-4-yl]-1,4,5,7-tetrahydroindazole-3-carboxamide
   Show/Hide
C23H29N5O3S  1
1
IC50 = 57000 nM
   TI
   LI
   LO
   TS
CP0282317
N-[1-[(S)-(1,1-dioxothian-4-yl)-phenylmethyl]pyrazol-4-yl]-6,6-dimethyl-1,4,5,7-tetrahydroindazole-3-carboxamide
   Show/Hide
C25H31N5O3S  1
1
IC50 = 29000 nM
   TI
   LI
   LO
   TS
CP0373044
methyl (2S)-2-[[8-(hydroxyamino)-8-oxooctanoyl]amino]-3-(4-thiophen-2-ylphenyl)propanoate
   Show/Hide
C22H28N2O5S  1
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
CP0389762
12,13-(3,4-Cis-dihyroxy-1,6-hexyl)-6,7,12,13-tetrahydro-5-oxo-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole
   Show/Hide
C26H23N3O3  2
1
IC50 = 45 nM
   TI
   LI
   LO
   TS
2
IC50 = 616 nM
   TI
   LI
   LO
   TS
CP0409025
4-(2-Azido-6,7-dimethoxy-4-oxo-4H-quinazolin-3-yl)-butyric acid ethyl ester
   Show/Hide
C16H19N5O5  1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0415350
4-(6,7-Diacetoxy-1-oxo-1H-isoquinolin-2-yl)-butyric acid ethyl ester
   Show/Hide
C19H21NO7  1
1
IC50 = 40000 nM
   TI
   LI
   LO
   TS
CP0490425
4-(5-Chloro-6,7-dimethoxy-4-oxo-4H-quinazolin-3-yl)-butyric acid ethyl ester
   Show/Hide
C16H19ClN2O5  1
1
IC50 = 89000 nM
   TI
   LI
   LO
   TS
CP0492301
4-(6,7-Dimethoxy-5-nitro-4-oxo-4H-quinazolin-3-yl)-butyric acid ethyl ester
   Show/Hide
C16H19N3O7  1
1
IC50 > 25000 nM
   TI
   LI
   LO
   TS
CP0496335
(16S,17R)-16-{[3-(dimethylamino)pyrrolidin-1-yl]carbonyl}-16,17-dihydroxy-4,14,19-triazaheptacyclo[12.11.2.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]heptacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-3,5-dione
   Show/Hide
C31H29N5O5  1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0508893
4-(7-Amino-4-oxo-1,4-dihydro-2H-quinazolin-3-yl)-butyric acid ethyl ester
   Show/Hide
C14H19N3O3  1
1
IC50 > 50000 nM
   TI
   LI
   LO
   TS
CP0510089
12,13-(1,6-hex-cis-3-enyl)-6,7,12,13-tetrahydro-5-oxo-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole
   Show/Hide
C26H21N3O  1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0513642
methyl (2S)-2-[[9-(hydroxyamino)-9-oxononanoyl]amino]-3-(4-phenylphenyl)propanoate
   Show/Hide
C25H32N2O5  1
1
IC50 = 2700 nM
   TI
   LI
   LO
   TS
CP0523269
2-[4-[[5-fluoro-4-[3-(prop-2-enoylamino)anilino]pyrimidin-2-yl]amino]phenoxy]ethyl N-(pyridin-3-ylmethyl)carbamodithioate
   Show/Hide
C28H26FN7O2S2  1
1
IC50 = 2490 nM
   TI
   LI
   LO
   TS
CP0524370
12,13-(2-hydroxy-butan-1,4-yl)-12,13-dihydro-5,7-dioxo-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole
   Show/Hide
C24H17N3O3  1
1
IC50 = 5670 nM
   TI
   LI
   LO
   TS
CP0524849
12,13-[2-carboxy-cis-2,3-dihydroxy-1,4-butyl]-6,7,12,13-tetrahyhydro-5,7-dioxo-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole
   Show/Hide
C25H17N3O6  1
1
IC50 = 222 nM
   TI
   LI
   LO
   TS
CP0524850
12,13-(2,3-cis-dihydroxy-pentan-1,5-yl)-12,13-dihydro-5,7-dioxo-6H-indolo[2,3-a]pyrrolo[3,4-c]carbazole
   Show/Hide
C25H19N3O4  1
1
IC50 > 10000 nM
   TI
   LI
   LO
   TS
CP0525946
4-(4-Bromo-6,7-dihydroxy-1-oxo-1H-isoquinolin-2-yl)-butyric acid ethyl ester
   Show/Hide
C15H16BrNO5  1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0527639
4-(5-Amino-6,7-dimethoxy-4-oxo-4H-quinazolin-3-yl)-butyric acid ethyl ester
   Show/Hide
C16H21N3O5  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0552095
3-[4-[(4-chlorophenyl)carbamoylamino]phenyl]-N-hydroxypropanamide
   Show/Hide
C16H16ClN3O3  1
1
IC50 = 410 nM
   TI
   LI
   LO
   TS
CP0645518
ethyl 2-amino-6-methyl-4-(1-cyano-2-ethoxy-2-oxoethyl)-4Hchromene-3-carboxylate
   Show/Hide
C18H20N2O5  1
1
GI50 = 29000 nM
   TI
   LI
   LO
   TS
CP0645519
ethyl2-amino-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
   Show/Hide
C17H18N2O5  1
1
GI50 = 66000 nM
   TI
   LI
   LO
   TS
CP0656008
ethyl 2-amino-6-n-propyl-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
   Show/Hide
C20H24N2O5  1
1
GI50 = 5200 nM
   TI
   LI
   LO
   TS
CP0657487
(S,E)-16-hydroxy-14-methoxy-3-methyl-3,4,9,10,11,12-hexahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione
   Show/Hide
C19H24O5  2
1
IC50 = 9700 nM
   TI
   LI
   LO
   TS
2
IC50 = 13000 nM
   TI
   LI
   LO
   TS
CP0657489
(3S,5Z,8S,9R,11E)-8,9,16-trihydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione
   Show/Hide
C19H22O7  1
1
IC50 = 7000 nM
   TI
   LI
   LO
   TS
CP0689377
SPEBRUTINIB
   Show/Hide
C22H22FN5O3  1
1
IC50 = 6700 nM
   TI
   LI
   LO
   TS
CP0705371
12,13-[2-carbomethoxy-1,4-but-cis-2-enyl]-6,7,12,13-tetrahyhydro-5,7-dioxo-5H-indolo[2,3-a]pyrrolo[3,4-c]carbazole
   Show/Hide
C26H17N3O3  1
1
IC50 = 575 nM
   TI
   LI
   LO
   TS
CP0708402
ethyl 2-amino-6-cyclopentyl-4-(1-cyano-2-ethoxy-2-oxoethyl)-4H-chromene-3-carboxylate
   Show/Hide
C22H26N2O5  1
1
GI50 = 3500 nM
   TI
   LI
   LO
   TS
CP0711847
(S,5E,11E)-16-hydroxy-14-methoxy-3-methyl-3,4,9,10-tetrahydro-1H-benzo[c][1]oxacyclotetradecine-1,7(8H)-dione
   Show/Hide
C19H22O5  2
1
IC50 = 8900 nM
   TI
   LI
   LO
   TS
2
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0756569
(S,9E,15Z)-2-ethyl-4,7-dimethyl-5,11-dimethylene-5,6,7,8,11,12,13,14-octahydrobenzo[14]annulene
   Show/Hide
C19H22O5  2
1
IC50 = 15400 nM
   TI
   LI
   LO
   TS
2
IC50 = 19500 nM
   TI
   LI
   LO
   TS
CP0859785
4-(5-Amino-6,7-dimethoxy-4-oxo-4H-quinazolin-3-yl)-butyric acid ethyl ester hydrochloride
   Show/Hide
C16H22ClN3O5  1
1
IC50 > 100000 nM
   TI
   LI
   LO
   TS
CP0953346
(4aS,5aR)-N-[1-[(S)-(1,1-dioxothian-4-yl)-phenyl-methyl]pyrazol-4-yl]-5a-methyl-4,4a,5,6-tetrahydro-1H-cyclopropa[f]indazole-3-carboxamide
   Show/Hide
C25H29N5O3S  1
1
IC50 = 29000 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Peripheral blood)
Cell Line Name Organism Disease
SET-2 Homo sapiens (Human) Adult acute megakaryoblastic leukemia
Mono-Mac-6 Homo sapiens (Human) Adult acute monocytic leukemia
HL-60 Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-13 Homo sapiens (Human) Adult acute myeloid leukemia
OCI-AML-2 Homo sapiens (Human) Adult acute myeloid leukemia
HL-60/ADR Homo sapiens (Human) Adult acute myeloid leukemia
MOLM-14 Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MDR Homo sapiens (Human) Adult acute myeloid leukemia
HL60/MRP Homo sapiens (Human) Adult acute myeloid leukemia
NALM-6 Homo sapiens (Human) Adult B acute lymphoblastic leukemia
MOLT-4 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
MOLT-4/CCR5 Homo sapiens (Human) Adult T acute lymphoblastic leukemia
Karpas-299 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
M-07e Homo sapiens (Human) Childhood acute megakaryoblastic leukemia
THP-1 Homo sapiens (Human) Childhood acute monocytic leukemia
MV4-11 Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Dual KO-STING Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Blue ISG Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-ASC-GFP Homo sapiens (Human) Childhood acute monocytic leukemia
PMNL Homo sapiens (Human) Childhood acute monocytic leukemia
THP1-Xblue Homo sapiens (Human) Childhood acute monocytic leukemia
SEM Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
SEMK2 Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Reh Homo sapiens (Human) Childhood B acute lymphoblastic leukemia
Jurkat E6.1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-CEM Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF/VCR1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB100 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM/VLB500 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-SS Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
HPB-ALL Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CCRF-SB Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
CEM-T4 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
J-Lat 10.6 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
12D7-MDR1 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
MDR CCRF vcr1000 Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
FGS7 Jurkat Homo sapiens (Human) Childhood T acute lymphoblastic leukemia
EoL-1 Homo sapiens (Human) Chronic eosinophilic leukemia, not otherwise specified
CII Homo sapiens (Human) Chronic lymphocytic leukemia
Ku812 Homo sapiens (Human) Chronic myelogenous leukemia, BCR-ABL1 positive
Ri-1 Homo sapiens (Human) Diffuse large B-cell lymphoma activated B-cell type
Daudi Homo sapiens (Human) EBV-related Burkitt lymphoma
HEL Homo sapiens (Human) Erythroleukemia
UKE-1 Homo sapiens (Human) Essential thrombocythemia
L-1236 Homo sapiens (Human) Hodgkin lymphoma
Granta-519 Homo sapiens (Human) Mantle cell lymphoma
JeKo-1 Homo sapiens (Human) Mantle cell lymphoma
Mino Homo sapiens (Human) Mantle cell lymphoma
HMC-1 Homo sapiens (Human) Mast cell leukemia
NK-92 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
NK Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
KHYG-1 Homo sapiens (Human) Natural killer cell lymphoblastic leukemia/lymphoma
RPMI-8226 Homo sapiens (Human) Plasma cell myeloma
OPM-2 Homo sapiens (Human) Plasma cell myeloma
U266B1 Homo sapiens (Human) Plasma cell myeloma
KMS-18 Homo sapiens (Human) Plasma cell myeloma
MM1.S Homo sapiens (Human) Plasma cell myeloma
MM1.R Homo sapiens (Human) Plasma cell myeloma
OPM-1 Homo sapiens (Human) Plasma cell myeloma
RPMI-8226/Dox40 Homo sapiens (Human) Plasma cell myeloma
HuT 78 Homo sapiens (Human) Sezary syndrome
H9 Homo sapiens (Human) Sezary syndrome
CREM010i-SS9-1 Homo sapiens (Human) Sickle cell disease
RBL-1 Rattus norvegicus (Rat) Rat leukemia
RBL-2H3 Rattus norvegicus (Rat) Rat leukemia
LCL Orang Asli K28 Homo sapiens (Human) -
JY Homo sapiens (Human) -
C.M.L. Homo sapiens (Human) -
BON Homo sapiens (Human) -
PBMC iPSC #1 Homo sapiens (Human) -
LCL 721 Homo sapiens (Human) -